Life Science Focus https://www.lifesciencefocus.com The latest articles with business news. en They take the helm as Mölnlycke splits in two https://www.lifesciencefocus.com/article/view/1254681/they_take_the_helm_as_molnlycke_splits_in_two?ref=rss Tue, 03 Nov 2026 15:42:55 +0100 https://www.lifesciencefocus.com/article/view/1254681 Novartis ends BioArctic deal: “Nothing to do with BrainTransporter” https://www.lifesciencefocus.com/article/view/1254575/novartis_ends_bioarctic_deal_nothing_to_do_with_braintransporter?ref=rss Tue, 03 Nov 2026 11:27:39 +0100 https://www.lifesciencefocus.com/article/view/1254575 Five doctors charged in Swedish prescription fraud scheme https://www.lifesciencefocus.com/article/view/1254569/five_doctors_charged_in_swedish_prescription_fraud_scheme?ref=rss Tue, 03 Nov 2026 11:17:18 +0100 https://www.lifesciencefocus.com/article/view/1254569 Child dies as measles cases surge across US https://www.lifesciencefocus.com/article/view/1254545/child_dies_as_measles_cases_surge_across_us?ref=rss Tue, 03 Nov 2026 10:39:44 +0100 https://www.lifesciencefocus.com/article/view/1254545 Lytix reports positive cancer data – plans larger trial https://www.lifesciencefocus.com/article/view/1254533/lytix_reports_positive_cancer_data_plans_larger_trial?ref=rss Tue, 03 Nov 2026 10:24:18 +0100 https://www.lifesciencefocus.com/article/view/1254533 AstraZeneca drops two early-stage prostate cancer drugs https://www.lifesciencefocus.com/article/view/1254266/astrazeneca_drops_two_earlystage_prostate_cancer_drugs?ref=rss Mon, 02 Nov 2026 13:17:41 +0100 https://www.lifesciencefocus.com/article/view/1254266 Major deal gives Fresenius access to 37 biosimilar candidates – “We are doubling down” https://www.lifesciencefocus.com/article/view/1254284/major_deal_gives_fresenius_access_to_37_biosimilar_candidates_we_are_doubling_down?ref=rss Mon, 02 Nov 2026 11:21:25 +0100 https://www.lifesciencefocus.com/article/view/1254284 Atlas Antibodies replaces CEO – brings in former OssDsign chief https://www.lifesciencefocus.com/article/view/1254243/atlas_antibodies_replaces_ceo_brings_in_former_ossdsign_chief?ref=rss Mon, 02 Nov 2026 10:30:12 +0100 https://www.lifesciencefocus.com/article/view/1254243 EU Biotech Act: Extended drug protection sparks debate https://www.lifesciencefocus.com/article/view/1254222/eu_biotech_act_extended_drug_protection_sparks_debate?ref=rss Mon, 02 Nov 2026 09:56:54 +0100 https://www.lifesciencefocus.com/article/view/1254222 Alligator Bioscience sells mitazalimab – potential to receive more than 1 billion https://www.lifesciencefocus.com/article/view/1254181/alligator_bioscience_sells_mitazalimab_potential_to_receive_more_than_1_billion?ref=rss Mon, 02 Nov 2026 08:43:42 +0100 https://www.lifesciencefocus.com/article/view/1254181 Eli Lilly drops Alzheimer’s drug candidate after phase II trial https://www.lifesciencefocus.com/article/view/1253994/eli_lilly_drops_alzheimers_drug_candidate_after_phase_ii_trial?ref=rss Fri, 30 Oct 2026 13:39:42 +0100 https://www.lifesciencefocus.com/article/view/1253994 AstraZeneca unveils major cost-cutting drive https://www.lifesciencefocus.com/article/view/1254018/astrazeneca_unveils_major_costcutting_drive?ref=rss Fri, 30 Oct 2026 10:04:59 +0100 https://www.lifesciencefocus.com/article/view/1254018 Sobi proposes Börje Ekholm as new chair https://www.lifesciencefocus.com/article/view/1253976/sobi_proposes_borje_ekholm_as_new_chair?ref=rss Fri, 30 Oct 2026 08:46:49 +0100 https://www.lifesciencefocus.com/article/view/1253976 SynAct Pharma signs first dengue drug deal https://www.lifesciencefocus.com/article/view/1253914/synact_pharma_signs_first_dengue_drug_deal?ref=rss Thu, 29 Oct 2026 14:57:55 +0100 https://www.lifesciencefocus.com/article/view/1253914 Lilly’s triple-G drug outperforms Ozempic in head-to-head trial https://www.lifesciencefocus.com/article/view/1253798/lillys_tripleg_drug_outperforms_ozempic_in_headtohead_trial?ref=rss Thu, 29 Oct 2026 10:50:25 +0100 https://www.lifesciencefocus.com/article/view/1253798 Ferring to buy IVF biotech in billion-dollar deal https://www.lifesciencefocus.com/article/view/1253783/ferring_to_buy_ivf_biotech_in_billiondollar_deal?ref=rss Thu, 29 Oct 2026 10:12:52 +0100 https://www.lifesciencefocus.com/article/view/1253783 Danish drug candidate shows great response to two cancer types https://www.lifesciencefocus.com/article/view/1253659/danish_drug_candidate_shows_great_response_to_two_cancer_types?ref=rss Thu, 29 Oct 2026 08:23:45 +0100 https://www.lifesciencefocus.com/article/view/1253659 Abbott sharpens cancer test – detects smaller traces of tumour DNA https://www.lifesciencefocus.com/article/view/1253562/abbott_sharpens_cancer_test_detects_smaller_traces_of_tumour_dna?ref=rss Wed, 28 Oct 2026 16:27:41 +0100 https://www.lifesciencefocus.com/article/view/1253562 Cell therapy scrapped after patient deaths in trial — 94 per cent of staff laid off https://www.lifesciencefocus.com/article/view/1253665/cell_therapy_scrapped_after_patient_deaths_in_trial_94_per_cent_of_staff_laid_off?ref=rss Wed, 28 Oct 2026 15:37:05 +0100 https://www.lifesciencefocus.com/article/view/1253665 Björn Ursing: “What happens when trust in science erodes?” https://www.lifesciencefocus.com/article/view/1253544/bjorn_ursing_what_happens_when_trust_in_science_erodes?ref=rss Wed, 28 Oct 2026 13:35:45 +0100 https://www.lifesciencefocus.com/article/view/1253544 Danish heart drug developer heads for Swedish stock market https://www.lifesciencefocus.com/article/view/1253551/danish_heart_drug_developer_heads_for_swedish_stock_market?ref=rss Wed, 28 Oct 2026 11:08:50 +0100 https://www.lifesciencefocus.com/article/view/1253551 AstraZeneca considers move into cancer vaccines https://www.lifesciencefocus.com/article/view/1253462/astrazeneca_considers_move_into_cancer_vaccines?ref=rss Wed, 28 Oct 2026 08:45:49 +0100 https://www.lifesciencefocus.com/article/view/1253462 AlzeCure CEO steps down – co-founder takes over https://www.lifesciencefocus.com/article/view/1253461/alzecure_ceo_steps_down_cofounder_takes_over?ref=rss Wed, 28 Oct 2026 08:42:49 +0100 https://www.lifesciencefocus.com/article/view/1253461 Xbrane wins long-awaited FDA approval for eye drug biosimilar https://www.lifesciencefocus.com/article/view/1253410/xbrane_wins_longawaited_fda_approval_for_eye_drug_biosimilar?ref=rss Tue, 27 Oct 2026 16:31:52 +0100 https://www.lifesciencefocus.com/article/view/1253410 New lung cancer combo shown to extend survival by eight months https://www.lifesciencefocus.com/article/view/1253353/new_lung_cancer_combo_shown_to_extend_survival_by_eight_months?ref=rss Tue, 27 Oct 2026 14:59:47 +0100 https://www.lifesciencefocus.com/article/view/1253353